Literature DB >> 19344972

Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus.

Minoo Yaghmaei1, Mohammad Hashemi, Abdolsamad Shikhzadeh, Mojgan Mokhtari, Abbasali Niazi, Saeid Ghavami.   

Abstract

BACKGROUND: Alpha-1-antitrpsin (AAT) is the main antiprotease of plasma. Concentration of serum alpha-1-antitrypsin (AAT) may not be delegate of the functional capacity of this antiprotease. To our knowledge there is not any report regarding the functional level of AAT in gestational diabetes mellitus (GDM). The aim of the present study was to determine serum trypsin inhibitory capacity (sTIC) in gestational diabetes mellitus.
METHODS: This case-control study was performed in 41 GDM and 40 healthy pregnant women. sTIC was measured by enzymatic assay.
RESULTS: The serum trypsin inhibitory capacity was significantly lower (p<0.001) in GDM (5.84+/-2.27 micromol/min/ml) than healthy pregnant women (7.24+/-1.91 micromol/min/ml).
CONCLUSION: In gestational diabetes mellitus reduction of serum trypsin inhibitory capacity may be due to non-enzymatic glycosylation of alpha-1-antitrypsin or oxidation of methionin in the active site of alpha-1-antitrypsin which remains to be cleared.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344972     DOI: 10.1016/j.diabres.2009.03.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

1.  α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Authors:  Galit Shahaf; Hadas Moser; Eyal Ozeri; Mark Mizrahi; Avishag Abecassis; Eli C Lewis
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

Review 2.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

3.  Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice.

Authors:  Sandhya Subramanian; Galit Shahaf; Eyal Ozeri; Lisa M Miller; Arthur A Vandenbark; Eli C Lewis; Halina Offner
Journal:  Metab Brain Dis       Date:  2011-03-25       Impact factor: 3.584

4.  Alpha-1 Antitrypsin Therapy for Autoimmune Disorders.

Authors:  Sihong Song
Journal:  Chronic Obstr Pulm Dis       Date:  2018-10-05

5.  Effect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes.

Authors:  Siyoung Lee; Youngmin Lee; Kwangwon Hong; Jaewoo Hong; Suyoung Bae; Jida Choi; Hyunjhung Jhun; Areum Kwak; Eunsom Kim; Seunghyun Jo; Charles A Dinarello; Soohyun Kim
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

Review 6.  Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?

Authors:  Gustavo Ortiz; Juan P Salica; Eduardo H Chuluyan; Juan E Gallo
Journal:  Biol Res       Date:  2014-11-18       Impact factor: 5.612

7.  Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.

Authors:  Jang-Hee Cho; Hye-Myung Ryu; Eun-Joo Oh; Ju-Min Yook; Ji-Sun Ahn; Hee-Yeon Jung; Ji-Young Choi; Sun-Hee Park; Yong-Lim Kim; Ihm Soo Kwak; Chan-Duck Kim
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

Review 8.  Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus.

Authors:  Sangmi S Park; Romy Rodriguez Ortega; Christina W Agudelo; Jessica Perez Perez; Brais Perez Gandara; Itsaso Garcia-Arcos; Cormac McCarthy; Patrick Geraghty
Journal:  Medicina (Kaunas)       Date:  2021-04-20       Impact factor: 2.430

9.  Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus.

Authors:  Elena G Bernea; Viorel I Suica; Elena Uyy; Aurel Cerveanu-Hogas; Raluca M Boteanu; Luminita Ivan; Iuliana Ceausu; Doina A Mihai; Constantin Ionescu-Tîrgoviște; Felicia Antohe
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

10.  Therapeutic potential of alpha-1 antitrypsin in human disease.

Authors:  Minsun Kim; Qing Cai; Youngman Oh
Journal:  Ann Pediatr Endocrinol Metab       Date:  2018-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.